We are very pleased to announced that VCCP Health have been appointed by Teva to handle the global launch of a new orphan treatment for the rare genetic condition, Huntington’s Disease.
We are delighted to announced that Besin’s Healthcare have appointed VCCP Health to work on their portfolio of Male and Female Health products.
For the second year in a row, VCCP Health have taken home the Best Press/Outdoor Campaign award for the 2013 Prevalin campaign at the OTC Marketing Awards.
The press campaign focused on Prevalin’s speeds, enabling hay fever sufferers to get outside quicker and not miss out on daily life. This message was brought to life in three print executions appearing in the London Metro during the key hay fever period, each suggesting that someone was “missing out” while waiting for their antihistamines to kick-in.
3rd February 2014
VCCP Health were the most awarded agency of the night at this year’s PM Society Advertising Awards, taking home 3 trophies for the Copaxone “Good days, not lost days” campaign for Teva, in the International Core Campaign, Secondary Care Campaign and Secondary Care Advertisement categories.
The Copaxone campaign was also the most awarded individual campaign winning a High Commendation (Journal Advertisement Campaign) and a Commendation in addition to the 3 wins.
VCCP Health were also awarded a further Commendation for the XTANDI “Contain the Danger” campaign in the Secondary Care Campaign award category.
For more details and all the winners see the PM Society website.
17th December 2013
30th November 2013
We are happy to announce that we are now working with Mundipharma International on their pan-European Pain franchise. The work has already started and we are excited for the new campaign to launch mid-2014.
28th November 2013
Roche and VCCP Health were delighted to take home the Launch Excellence award at the 2013 PMEAs for their collaboration on the global launch of Zelboraf.
The judges commented: “Zelboraf is a brilliant product but even brilliant products don’t succeed without brilliant people behind them. The personalization approach and messaging for different stakeholder groups was clear and very compelling. The launch strategy was comprehensive and detailed and delivered impressive results that exceeded all targets.”
The PMEAs aim to recognise and encourage effectiveness and best marketing/business practice, in the pharmaceutical industry, that deliver clearly identifiable benefits for stakeholders and for the company.
15th June 2013
Isla Forghani joins VCCP Health as an Account Manager. Isla started her career as a Marketing Assistant at Janssen-Cilag. Since then, Isla has moved to work within healthcare advertising where for the past 4 years she has launched a combination of professional, patient and consumer health global campaigns across a range of therapy areas including andrology, erectile dysfunction, vascular health, ophthalmology and orthopaedic medical devices.
1st April 2013
Kate joins VCCP as an Account Manager. Kate started her career working in the marketing and communications industry for both consumer and healthcare brands, where she has over four years’ experience. Since choosing to focus exclusively on healthcare communications, Kate has worked with a range of clients including Roche, GSK and Pfizer while helping to deliver campaigns for brands such as Mabthera RA, Xeloda and Clarityn. Kate is passionate about working within the mental health field and has first-hand experience of working with patients with eating disorders, depression, and suicidal tendencies whilst completing patient focused volunteer work.
18th March 2013
Elle Young joins VCCP as an Account Manager. Elle started her science career with the Ministry of Defence and transitioned into healthcare advertising two years ago. Since then she has worked on Global and UK accounts covering a wide range of therapy areas includes diabetes, neuropathic pain, overactive bladder, travel vaccines, prostate cancer and MS.